Publicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (2)

2019

  1. CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC

    Cancer Research, Vol. 79, Núm. 17, pp. 4439-4452

2015

  1. Intratumoral heterogeneity in EGFR-mutant NSCLC results in divergent resistance mechanisms in response to EGFR tyrosine kinase inhibition

    Cancer Research, Vol. 75, Núm. 20, pp. 4372-4383